Stifel Nicolaus reiterated their buy rating on shares of HB Fuller (NYSE:FUL) in a research note released on Friday, Stock Target Advisor reports. Stifel Nicolaus currently has a $54.00 target price on the specialty chemicals company’s stock.

Several other research firms have also recently commented on FUL. ValuEngine raised HB Fuller from a sell rating to a hold rating in a research note on Friday, May 1st. JPMorgan Chase & Co. upgraded HB Fuller from a neutral rating to an overweight rating and set a $34.00 price objective for the company in a research report on Friday, April 17th. Citigroup dropped their price objective on HB Fuller from $50.00 to $30.00 and set a neutral rating for the company in a report on Friday, March 27th. TheStreet lowered shares of HB Fuller from a b- rating to a c+ rating in a research note on Thursday, March 5th. Finally, Zacks Investment Research cut shares of HB Fuller from a hold rating to a sell rating in a research report on Wednesday, June 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of Hold and a consensus price target of $48.43.

HB Fuller stock opened at $42.50 on Friday. The business’s fifty day moving average is $39.01 and its two-hundred day moving average is $40.61. The firm has a market cap of $2.19 billion, a P/E ratio of 17.86, a P/E/G ratio of 2.48 and a beta of 1.81. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.19 and a current ratio of 1.89. HB Fuller has a 52 week low of $23.68 and a 52 week high of $52.40.

HB Fuller (NYSE:FUL) last announced its earnings results on Wednesday, June 24th. The specialty chemicals company reported $0.68 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.55 by $0.13. The company had revenue of $675.00 million for the quarter, compared to analyst estimates of $664.28 million. HB Fuller had a net margin of 4.43% and a return on equity of 11.89%. HB Fuller’s quarterly revenue was down 11.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.88 earnings per share. On average, equities research analysts predict that HB Fuller will post 2.35 earnings per share for the current year.

Hedge funds have recently bought and sold shares of the business. Chevy Chase Trust Holdings Inc. acquired a new position in HB Fuller in the 4th quarter valued at about $27,000. Advisor Group Holdings Inc. acquired a new stake in HB Fuller during the first quarter worth about $27,000. Ellevest Inc. increased its holdings in HB Fuller by 117.1% in the 1st quarter. Ellevest Inc. now owns 1,196 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 645 shares during the period. Tower Research Capital LLC TRC raised its position in shares of HB Fuller by 367.5% in the 1st quarter. Tower Research Capital LLC TRC now owns 1,178 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 926 shares in the last quarter. Finally, FMR LLC lifted its holdings in shares of HB Fuller by 37.1% during the 4th quarter. FMR LLC now owns 1,005 shares of the specialty chemicals company’s stock worth $52,000 after acquiring an additional 272 shares during the period. Hedge funds and other institutional investors own 96.71% of the company’s stock.

About HB Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.

Read More: What is a management fee?

Analyst Recommendations for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.